Isabel S. Jerchel

475 total citations
12 papers, 362 citations indexed

About

Isabel S. Jerchel is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Isabel S. Jerchel has authored 12 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Surgery. Recurrent topics in Isabel S. Jerchel's work include Acute Lymphoblastic Leukemia research (5 papers), Fibroblast Growth Factor Research (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Isabel S. Jerchel is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Fibroblast Growth Factor Research (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Isabel S. Jerchel collaborates with scholars based in Netherlands, Germany and United States. Isabel S. Jerchel's co-authors include Monique L. den Boer, Judith M. Boer, Rob Pieters, Martin A. Horstmann, Gabriele Escherich, Ingrid M. Ariës, Aurélie Boeree, Cesca van de Ven, Nicolle Besselink and Marco J. Koudijs and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Cancer Research.

In The Last Decade

Isabel S. Jerchel

12 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel S. Jerchel Netherlands 8 121 106 93 82 54 12 362
Florin Tripon Romania 12 70 0.6× 81 0.8× 140 1.5× 50 0.6× 11 0.2× 42 381
Filiz Özen Türkiye 9 22 0.2× 114 1.1× 98 1.1× 48 0.6× 34 0.6× 34 350
Aı́da Falcón de Vargas Venezuela 6 312 2.6× 69 0.7× 70 0.8× 26 0.3× 65 1.2× 9 600
Grażyna Kurzawińska Poland 10 44 0.4× 51 0.5× 37 0.4× 95 1.2× 37 0.7× 55 344
Eimantas Švedas Sweden 8 26 0.2× 32 0.3× 71 0.8× 54 0.7× 38 0.7× 10 334
Bérengère Koehl France 12 23 0.2× 165 1.6× 84 0.9× 79 1.0× 12 0.2× 47 487
F. Bourgeois United States 12 47 0.4× 22 0.2× 89 1.0× 104 1.3× 42 0.8× 28 368
Wellington L. Paul United States 8 127 1.0× 96 0.9× 59 0.6× 70 0.9× 28 0.5× 13 483
Yuki Kamimoto Japan 12 47 0.4× 48 0.5× 65 0.7× 233 2.8× 32 0.6× 27 432
Takayuki Okamoto Japan 12 19 0.2× 60 0.6× 169 1.8× 23 0.3× 34 0.6× 57 469

Countries citing papers authored by Isabel S. Jerchel

Since Specialization
Citations

This map shows the geographic impact of Isabel S. Jerchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel S. Jerchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel S. Jerchel more than expected).

Fields of papers citing papers by Isabel S. Jerchel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel S. Jerchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel S. Jerchel. The network helps show where Isabel S. Jerchel may publish in the future.

Co-authorship network of co-authors of Isabel S. Jerchel

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel S. Jerchel. A scholar is included among the top collaborators of Isabel S. Jerchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel S. Jerchel. Isabel S. Jerchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jerchel, Isabel S., Ingrid M. Ariës, Judith M. Boer, et al.. (2019). Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia. Scientific Reports. 9(1). 1875–1875. 5 indexed citations
2.
Politz, Oliver, Isabel S. Jerchel, Alexander M. Walter, et al.. (2019). Abstract 4793: Preclinical evaluation of the combination rogaratinib and copanlisib in HNSCC and HCC in preclinical in vitro and in vivo models. Cancer Research. 79(13_Supplement). 4793–4793. 1 indexed citations
3.
Jerchel, Isabel S., Pascale Lejeune, Rita Lampignano, et al.. (2019). Abstract 3080: Activity of pan-FGFR inhibitor rogaratinib and PI3K inhibitor copanlisib in preclinical urothelial bladder cancer models. 3080–3080. 2 indexed citations
4.
Jerchel, Isabel S., Pascale Lejeune, Rita Lampignano, et al.. (2019). Abstract 3080: Activity of pan-FGFR inhibitor rogaratinib and PI3K inhibitor copanlisib in preclinical urothelial bladder cancer models. Cancer Research. 79(13_Supplement). 3080–3080. 2 indexed citations
5.
Steeghs, Elisabeth M. P., Isabel S. Jerchel, Judith M. Boer, et al.. (2017). JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia. Oncotarget. 8(52). 89923–89938. 37 indexed citations
6.
Jerchel, Isabel S., Ingrid M. Ariës, Elisabeth M. P. Steeghs, et al.. (2017). RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. Leukemia. 32(4). 931–940. 74 indexed citations
7.
Vet, Nienke J., Janneke M. Brussee, Matthijs de Hoog, et al.. (2016). Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children. American Journal of Respiratory and Critical Care Medicine. 194(1). 58–66. 78 indexed citations
8.
Steeghs, Elisabeth M. P., Isabel S. Jerchel, Judith M. Boer, et al.. (2016). JAK2 Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 128(22). 583–583. 13 indexed citations
9.
IJspeert, Hanna, Jacob Rozmus, Klaus Schwarz, et al.. (2016). XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood. 128(5). 650–659. 25 indexed citations
10.
Jerchel, Isabel S., Ingrid M. Ariës, Elisabeth M. P. Steeghs, et al.. (2016). RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 128(22). 4087–4087. 14 indexed citations
11.
Ariës, Ingrid M., Isabel S. Jerchel, Lieke C. J. van den Berk, et al.. (2014). EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion. Leukemia. 28(9). 1828–1837. 51 indexed citations
12.
Schroeter, Marco R., Isabel S. Jerchel, Maren Leifheit‐Nestler, et al.. (2013). Leptin-Dependent and Leptin-Independent Paracrine Effects of Perivascular Adipose Tissue on Neointima Formation. Arteriosclerosis Thrombosis and Vascular Biology. 33(5). 980–987. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026